Kailera Therapeutics, Inc. (KLRA)

17.72 +1.18 (+7.13%) USD  |  NASDAQ  |  Aug 25, 16:00
17.60 -0.12 (-0.68%) After-Hours: 16:14
More

Kailera Therapeutics EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Fiscal Year Chart
Start Trial

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
July 07, 2026 --
Date Value
May 27, 2026 --
May 12, 2026 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Sana Biotechnology, Inc. Upgrade
Parabilis Medicines, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade